Genius Brands International Inc diskutieren
Kartoon Studios Inc.
WKN: A3D6A1 / Symbol: GNUS / Name: Kartoon Studios / Aktie / Medien & Verlagswesen / Micro Cap /
0,70 €
-2,78 %
SecteurProduction de spectacles Agenda 13/11 Publication de résultats
Operates as a brand management company, which creates and licenses multimedia content
Genius Brands International, Inc. is a content and brand management company, which engages in developing, producing, marketing, and licensing branded children’s entertainment properties and consumer products for media distribution and retail channels.
The firm acts as a licensing agent for certain brands, such as Llama Llama, Psycho Bunny, From Frank, and Celessence Technologies.
The company was founded by Balaban Howard Alan on January 2, 2006 and is headquartered in Beverly Hills, CA.
Genius Brands International, Inc. is a content and brand management company, which engages in developing, producing, marketing, and licensing branded children’s entertainment properties and consumer products for media distribution and retail channels.
The firm acts as a licensing agent for certain brands, such as Llama Llama, Psycho Bunny, From Frank, and Celessence Technologies.
The company was founded by Balaban Howard Alan on January 2, 2006 and is headquartered in Beverly Hills, CA.
Nombre d'employés : 26 personnes.
(Zielkurs erreicht)
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy mit Kursziel 5,0
Sell Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Buy Genius Brands International Inc
Sell Genius Brands International Inc
Sell Genius Brands International Inc
Sell Genius Brands International Inc
Sell Genius Brands International Inc
Sell Genius Brands International Inc
Neueste Beiträge
Vassago1 in Fate Therapeutics Inc. diskutieren